Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
How It Works 
News - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI Summary - About
Intuitive Surgical Inc(ISRG)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Stock price based on last close Advisory Performance History (Simulated)
Upturn Advisory & Investor View for ISRG
10/30/2026: ISRG (3-star) is a STRONG-BUY. BUY for 27 days. Simulated Profits (8.13%). Updated daily EoD!
Intuitive Surgical is a prominent developer of robotic-assisted surgical systems, best known for its da Vinci platform. The company has a leading position in the medical device sector, supported by a significant installed base and a lucrative recurring revenue stream from instruments and services. Its primary growth story revolves around the continued adoption of robotics in new surgical specialties and the rollout of next-generation systems. However, investors must consider risks such as high valuation, increasing competition from large conglomerates, and sensitivity to hospital capital budgets. Intuitive Surgical is generally suited for growth-oriented investors who prioritize technological market leadership over immediate dividend income.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company operates in a secular growth industry with strong, recurring revenue streams. |
| Momentum investor | Strong fit while signal remains positive | The stock often exhibits strong price trends tied to consistent earnings growth and market expansion. |
| Value investor | Weak fit | The stock historically trades at a premium valuation relative to earnings due to its market leadership. |
| Dividend investor | Weak fit | The company does not pay a cash dividend, focusing instead on reinvestment. |
| Low-risk investor | Mixed fit | While the business quality is high, the stock's valuation and volatility may be unsuitable for very conservative portfolios. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | High growth expectations can lead to significant price swings during market corrections. |
| Valuation risk | High | The stock often trades at elevated multiples, which may limit upside if growth slows. |
| Competition risk (Robotic Surgery Entrants) | Medium / high | Large incumbents like JNJ and MDT are investing heavily to challenge Intuitive's market share. |
| Business quality | Strong | High recurring revenue from instruments and services provides a durable competitive advantage. |
| Dividend income | Low / none | Investors looking for regular income will not find it with this stock. |
| Execution risk | Medium | Successfully managing the transition to new platforms like da Vinci 5 is critical for maintaining growth. |
Analysis of Past Performance
Type Stock | Historic Profit 53.24% | Avg. Invested days 67 | Today’s Advisory Strong Buy |
Upturn Advisory Rating  | Upturn Advisory Performance  3.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 10/30/2026 |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals
Financial Health Rating
Growth Momentum Score
Ownership
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue)
Economic Dimensions
Quantitative Style Profile
Style Classification
Quality Focused
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 158.54B USD | Price to earnings Ratio 54.26 | 1Y Target Price 482.63 |
Price to earnings Ratio 54.26 | 1Y Target Price 482.63 | ||
Volume (30-day avg) 2.3M shares | Beta 1.46 | 52 Weeks Range 328.57 - 603.88 | Updated Date 10/30/2026 |
52 Weeks Range 328.57 - 603.88 | Updated Date 10/30/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 8.27 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Instruments and Accessories | Single-use surgical tools and drapes for the da Vinci system. | This is a recurring revenue stream that grows as more procedures are performed. |
| Systems | Direct sales and leasing of da Vinci and Ion surgical platforms. | Capital equipment sales provide the foundation for future recurring instrument revenue. |
| Services | Annual maintenance contracts and training for hospital staff. | Provides stable, predictable cash flow after a system is installed. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date 2026-10-20 | When After Market | Estimate 2.13 | Actual 3 |
Profitability
Profit Margin 25.54% | Operating Margin (TTM) 33.29% |
Management Effectiveness
Return on Assets (TTM) 11.85% | Return on Equity (TTM) 17.93% |
Valuation
Trailing PE 54.26 | Forward PE 36.63 | Enterprise Value 152.88B | Price to Sales(TTM) 13.69 |
Enterprise Value 152.88B | Price to Sales(TTM) 13.69 | ||
Enterprise Value to Revenue 13.2 | Enterprise Value to EBITDA 33.44 | Shares Outstanding 353.28M | Shares Floating 344.60M |
Shares Outstanding 353.28M | Shares Floating 344.60M | ||
Percent Insiders 0.52 | Percent Institutions 91.22 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.